Testing effectiveness (Phase 2)Study completedNCT02518529
What this trial is testing
Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients
Who this might be right for
Gastric Cancer
Cancer Advances Inc. 41